Single-stage dilatation balloon drug coating processes

Single-stage dilatation balloon drug coating processes – Cheersonic

As a core device in interventional cardiovascular and peripheral vascular diagnosis and treatment, single-stage dilatation balloons have become the mainstream device for the pretreatment and precise treatment of vascular stenosis and occlusion lesions due to their advantages of simple structure, stable expansion, and wide adaptability. The drug coating on the balloon surface is a key factor determining its clinical efficacy and reducing restenosis rates. The coating material and spraying process directly affect drug release efficiency, vascular fit, and device safety. This article details the mainstream drug coating types for single-stage dilatation balloons and, combined with Cheersonic Ultrasonic’s proprietary spraying technology, deeply analyzes the core advantages of ultrasonic spraying in preparing balloon drug coatings, providing technical reference for the refined and large-scale production of high-end medical balloon devices.

I. Mainstream Drug Coating Types for Single-Stage Dilatation Balloons

The core principle of single-stage dilatation drug-coated balloons is to precisely release surface medication into the diseased vascular tissue by expanding the balloon to conform to the blood vessel wall, inhibiting vascular smooth muscle cell proliferation and reducing the risk of restenosis at its source. Currently, the mainstream coatings used in clinical applications and mass production development are mainly divided into three categories, adapting to different treatment scenarios and vascular lesion needs.
First is the anti-proliferative drug coating, which is the most widely used core coating type in clinical practice, with representative drugs including paclitaxel, rapamycin, and sirolimus. Paclitaxel coatings, in particular, exhibit strong stability and high drug retention, effectively inhibiting abnormal proliferation of vascular smooth muscle cells, making them suitable for the treatment of coronary artery and lower extremity peripheral vascular stenosis, and a classic coating option for single-stage dilatation balloons. Rapamycin and sirolimus coatings offer excellent immunosuppressive effects and a more gradual drug release, effectively reducing vascular inflammation, making them suitable for complex vascular lesions and cases requiring secondary intervention.

Secondly, there is the hydrophilic lubricating functional coating, with polyvinylpyrrolidone (PVP) as the core material. This coating does not have therapeutic effects and is mainly used to optimize the interventional performance of single-stage dilatation balloons. It can significantly reduce the frictional resistance during balloon entry into blood vessels, avoid scratches and damage to the inner wall of the blood vessel, improve the smoothness of instrument advancement, and reduce the risk of intraoperative thrombosis. It is widely used in the pretreatment of balloons for routine interventional procedures.
Finally, there is the antithrombotic composite coating, with heparin-polymer complex as the core material, which focuses on high biocompatibility and anticoagulant properties. This coating can effectively inhibit platelet aggregation, solve the risk of short-term thrombosis during and after single-stage dilatation balloon procedures, and is especially suitable for high-risk interventional scenarios such as neurointerventions and microvascular interventions, making up for the performance shortcomings of single antiproliferative coatings.

II. Core Advantages of Ultrasonic Spraying for Preparing Drug-Induced Coatings for Balloons

Traditional balloon coating processes often employ dip coating and high-pressure spraying, which suffer from numerous drawbacks, including uneven coating thickness, significant drug waste, easy damage to the balloon substrate, and unstable drug efficacy, making it difficult to meet the mass production standards of high-end single-stage dilatational medical balloons. Cheersonic ultrasonic medical-grade spraying equipment, relying on precise ultrasonic atomization technology, specifically addresses these industry pain points, making it the preferred process for mass production of drug-coated balloons, with significant core advantages.

First, the coating exhibits high uniformity, ensuring stable and controllable drug efficacy. Ultrasonic spraying atomizes the drug solution into submicron-sized uniform droplets through high-frequency ultrasonic vibration, achieving directional deposition spraying. This allows for precise control of coating thickness and density, ensuring consistent coating thickness across the entire single-stage dilatation balloon, without accumulation or missed areas. Compared to traditional processes, the coating prepared using this technology has stronger adhesion, reducing the likelihood of drug detachment during balloon dilation. This enables uniform and long-lasting drug release, significantly improving clinical treatment outcomes and effectively reducing the incidence of restenosis.

Secondly, it significantly improves drug utilization and reduces mass production costs. Paclitaxel, rapamycin, and other expensive medical drugs are costly, and traditional dip-coating processes only achieve a drug utilization rate of around 30%, while high-pressure spraying achieves less than 40%, resulting in substantial material loss. Cheersonic ultrasonic spraying employs a splash-free and dispersion-free directional deposition mode, achieving a drug raw material utilization rate of over 90%, greatly reducing waste of expensive drugs and effectively lowering the mass production cost of single-stage dilatational drug-eluting balloons, thus meeting the needs of large-scale industrial production.

Third, the process is gentle and non-destructive, ensuring the performance of the device’s substrate. Single-stage dilatation balloons often use flexible polymer substrates such as nylon and PEBAX. Traditional high-pressure spraying, with its airflow impact and high-temperature process, can easily lead to balloon deformation, substrate damage, and material aging. In contrast, ultrasonic spraying operates at low temperatures throughout, without mechanical extrusion or high-pressure airflow impact. The gentle processing does not damage the balloon’s substrate structure and mechanical properties, fully preserving the balloon’s dilatation stability and elasticity, thus ensuring the safety of the device in clinical use.

Fourth, it is clean and environmentally friendly, meeting medical aseptic production standards. Traditional spraying easily generates drug mist and liquid dispersion, causing not only workshop pollution but also occupational exposure risks to operators. Cheersonic ultrasonic spraying produces uniform and highly directional atomized particles with no excess liquid dispersion, ensuring controllable workshop cleanliness and fully complying with the aseptic and dust-free production specifications for high-end medical devices. Simultaneously, the digital control system can precisely adjust spraying parameters, achieving standardized and traceable coating processes that meet the stringent quality inspection requirements of medical devices.

III. Application Summary
With the iterative upgrades of interventional medical technologies, the demand for precise and safe production of single-stage dilatation drug-eluting balloons continues to increase. Different types of drug coatings endow balloons with differentiated diagnostic and therapeutic performance, and ultrasonic spraying technology, with its core advantages of good uniformity, high utilization rate, non-destructive processing, and compliant mass production, perfectly meets the preparation needs of various balloon coatings. Cheersonic Ultrasonic has deep expertise in the medical coating spraying field and can customize exclusive spraying solutions for different drug coating formulations, helping medical companies create high-quality, highly stable single-stage dilatation drug-eluting balloon products and promoting the upgrading of the interventional medical device industry.

About Cheersonic

Cheersonic is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.

Our coating solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

If you have any technical questions, customization demands, or procurement inquiries about ultrasonic atomization nozzles, feel free to contact our professional sales and technical team for detailed parameters, customized solutions, and industry application support.
Email: market2@cheersonic.com